3-methyllumiflavin: structure
ID Source | ID |
---|---|
PubMed CID | 87733 |
SCHEMBL ID | 14399199 |
MeSH ID | M0052336 |
Synonym |
---|
isoalloxazine, 3,7,8,10-tetramethyl- |
benzo[g]pteridine-2,4(3h,10h)-dione, 3,7,8,10-tetramethyl- |
3-methyllumiflavin |
benzo(g)pteridine-2,4(3h,10h)-dione, 3,7,8,10-tetramethyl- |
3,7,8,10-tetramethylbenzo[g]pteridine-2,4-dione |
18636-32-3 |
SCHEMBL14399199 |
DSUJCACXEBHAAS-UHFFFAOYSA-N |
3-methyllumiflavine |
3,7,8,10-tetramethylbenzo[g]pteridine-2,4(3h,10h)-dione |
3,6,7,9-tetramethylisoalloxazine |
DTXSID60171881 |
3-methyl-lumiflavine |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.42) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |